ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
Conversion Labs Inc

Conversion Labs Inc (CVLB)

29.40
0.00
(0.00%)
終値: 11月5日 6:00AM
29.40
0.00
( 0.00% )
取引時間後: -

個人投資家向けのプロ仕様のツール。

主要統計と詳細

通貨
29.40
買値
29.06
売値
29.89
出来高
-
0.00 日の範囲 0.00
0.00 52 週間の範囲 0.00
時価総額
前日終値
29.40
始値
-
時刻
最終取引時間
-
財務取引量
-
VWAP
-
平均取引量 (3 か月)
-
発行済株式数
37,979,000
配当利回り
-
PER
-7.05
1 株当たり利益 (EPS)
-0.62
歳入
152.55M
純利益
-23.7M

Conversion Labs Inc について

Conversion Labs Inc is a health and wellness-focused e-commerce company with a portfolio of online direct-to-consumer brands. The company's portfolio of brands includes proprietary over-the-counter products as well as prescription medications. The company also provides online physician consultations... Conversion Labs Inc is a health and wellness-focused e-commerce company with a portfolio of online direct-to-consumer brands. The company's portfolio of brands includes proprietary over-the-counter products as well as prescription medications. The company also provides online physician consultations directly to consumers. In addition to its healthcare platform, the company also offers online direct-response software as a service business that allows users to convert, edit, sign and share PDF files. 詳細を表示

セクター
Manufacturing Industries,nec
業界
Manufacturing Industries,nec
ウェブサイト
本社
Wilmington, Delaware, USA
設立
-

CVLB 最新ニュース

Conversion Labs Begins Trading Under New Company Name, LifeMD, and Ticker Symbol, LFMD

NEW YORK, Feb. 22, 2021 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (NASDAQ: CVLB) (NASDAQ: LFMD), a leading direct-to-patient telehealth company, will begin trading at the opening of the market...

Conversion Labs to Present at the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference on Februar...

NEW YORK, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (NASDAQ: CVLB), a leading direct-to-patient telehealth company, has been invited to present at the BTIG Virtual MedTech, Digital...

Conversion Labs to Become Life MD™ with Launch of New Concierge Telehealth Services

NEW YORK, Feb. 12, 2021 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (NASDAQ: CVLB), a leading direct-to-patient telehealth company, will change its name to Life MD™ on February 22, followed by the...

Conversion Labs Appoints Seasoned Financial and Operational Executive, Marc Benathen, as Chief Financial Officer

NEW YORK, Feb. 05, 2021 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (NASDAQ: CVLB), a leading direct-to-consumer telemedicine company, has appointed Marc Benathen as chief financial officer...

Conversion Labs Increases Stake in Fast-Growing SaaS Subsidiary

NEW YORK, Jan. 28, 2021 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (NASDAQ: CVLB), a leading direct-to-consumer telemedicine company, has increased its stake in its legacy LegalSimpli Software...

Conversion Labs Expects 2020 Revenue up 205% to Record $38.0 Million, Subscription ARR up 525% to $26.0 Million

NEW YORK, Jan. 19, 2021 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (NASDAQ: CVLB), a leading direct-to-consumer telemedicine company, reported preliminary unaudited results for its fourth quarter...

Conversion Labs Appoints Leading Telehealth Professional, Dr. Anthony Puopolo, as Chief Medical Officer

NEW YORK, Jan. 11, 2021 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (NASDAQ: CVLB), a direct-to-consumer telemedicine company, has appointed licensed personal care and wellness physician and...

Conversion Labs to Present at the H.C. Wainwright Virtual BioConnect Conference on January 11, 2021

NEW YORK, Jan. 06, 2021 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (NASDAQ: CVLB), a direct-to-consumer telemedicine company, has been invited to present at H.C. Wainwright’s BioConnect...

Conversion Labs Appoints Digital Marketing Executive, Bryant Hussey, as Chief Digital Officer

NEW YORK, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (NASDAQ: CVLB), a direct-to-consumer telemedicine company, has appointed digital marketing expert and industry thought-leader...

Conversion Labs Annualized Revenue Run-Rate Hits $53.9 Million, up 332% vs. 2019, Driven by Subscriptions to an Expanding Sui...

NEW YORK, Dec. 15, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (NASDAQ: CVLB), a direct-to-consumer telemedicine and wellness company, reported its annualized revenue run-rate reached a...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
IDAIT Stamp Inc
US$ 0.3245
(33.21%)
9.52M
BNOXBionomics Ltd
US$ 0.25
(30.73%)
3.38M
PTIRGraniteShares 2X Long PLTR Daily ETF
US$ 54.8112
(25.45%)
52.26k
ALABAstera Labs Inc
US$ 83.252
(19.67%)
263.24k
QNSTQuinStreet Inc
US$ 23.9999
(18.75%)
6.73k
MQMarqeta Inc
US$ 4.17
(-30.03%)
550.8k
NVTSNavitas Semiconductor Corporation
US$ 2.37
(-9.54%)
170.29k
ABCLAbCellera Biologics Inc
US$ 2.6217
(-8.97%)
67.81k
CRUSCirrus Logic Inc
US$ 101.24
(-8.56%)
36.18k
BOOMDMC Global Inc
US$ 9.00
(-8.54%)
5.74k
IDAIT Stamp Inc
US$ 0.3241
(33.05%)
9.53M
NVDANVIDIA Corporation
US$ 136.70
(0.45%)
3.43M
BNOXBionomics Ltd
US$ 0.2478
(29.58%)
3.38M
ELABElevai Labs Inc
US$ 0.0203
(0.50%)
3.08M
PTONPeloton Interactive Inc
US$ 7.50
(0.00%)
2.05M

最近閲覧した銘柄

Delayed Upgrade Clock